Godly gift for arthritis pain
Big Pharma is at it again… Creating and selling a drug that causes thousands of heart attacks and strokes each year. In 2015, the FDA asked drug makers to strengthen their warning labels. Since then, most have listed their dangerous side effects on the bottle. But one manufacturer thought they didn’t have to warn people about their dangerous drug. They marketed their product as a “unique” breakthrough. They even published studies promising it was “safe for long-term use.” 1 The drug is a 7-year-old arthritis drug called Actemra. It’s made by the Swiss pharmaceutical company Roche. But a new investigation has linked it to at least 1,128 heart attack and stroke deaths. Thousands more have suffered serious side effects. These include heart failure, stroke and lung disease.2 Researchers did a side-by-side comparison of Actemra to other arthritis drugs. They found the rate of stroke and heart failure in Actemra patients was 1.5 times higher. So far, neither Roche nor the FDA has alerted patients or doctors to its deadly risks. It’s another example of why I recommend plant-based remedies to my patients. These safe medicines have been used for thousands of years. Like Boswellia serrata, or Indian frankincense. Back in Biblical days, it was even more highly prized than gold. And it’s one of the most effective treatments for arthritis pain and inflammation I’ve found. Ayurvedic healers have used it for centuries to treat art...
Publication date: Available online 19 March 2019Source: Marine ChemistryAuthor(s): Miguel A. Goñi, Elizabeth R. Corvi, Kylie A. Welch, Maggie Buktenica, Kaitlin Lebon, Yvan Alleau, Laurie W. JuranekAbstractClimate change is leading to marked decreases in the extent, thickness and persistence of sea ice in Polar Regions, especially during the later summer and fall seasons. The expanded open water domain during this period has the potential to drastically affect the hydrography, biogeochemistry and ecology of Arctic seas. In view of these rapid changes, the distributions of particulate organic matter in surface waters...
J. Mater. Chem. A, 2019, Accepted Manuscript DOI: 10.1039/C8TA09521C, PaperFurqan Almyahi, Thomas Rieks Andersen, Adam Fahy, Michael Dickinson, Krishna Feron, Warwick J. Belcher, Paul Dastoor The fabrication of organic photovoltaic devices from aqueous solar nanoparticle (ASNP) inks, or solar paints, is challenging; driven by the often competing requirements of maintaining emulsion stability whilst simultaneously facilitating... The content of this RSS Feed (c) The Royal Society of Chemistry
J. Mater. Chem. A, 2019, Accepted Manuscript DOI: 10.1039/C9TA01893J, CommunicationWeihai ZHANG, Juan Xiong, jinhua li, Walid A Daoud Guanidinium (GA) has been proposed as an effective organic cation in improving the stability of lead halide perovskite solar cells (PSCs). However, the reported efficiency of GA based PSCs is... The content of this RSS Feed (c) The Royal Society of Chemistry
In this study, a green and atom economic strategy has been developed to construct polybismaleimide-based microporous organic polymers (BMOPs). The preparation is achieved through one-step thermal-initiation homopolymerization of individual bismaleimide... The content of this RSS Feed (c) The Royal Society of Chemistry
Environ. Sci.: Processes Impacts, 2019, Accepted Manuscript DOI: 10.1039/C8EM00569A, PaperMichael J. Brophy, Allison Mackie, Yuri Park, Graham Gagnon Polar organic chemical integrative samplers (POCIS) were used in this study to explore passive sampling for the detection of microcystin-LR (MC-LR). POCIS were deployed in triplicate for a minimum of... The content of this RSS Feed (c) The Royal Society of Chemistry
Research ArticlesS. INAIDA, Y. SHOBUGAWA, S. MATSUNO, R. SAITO, H. SUZUKI,Epidemiology&Infection,Volume 144 Issue 12, pp 2561-2567Abstract
Research ArticlesNiccol ò Buetti, Jonas Marschall, Andrew Atkinson, Andreas Kronenberg,Infection Control&Hospital Epidemiology,Volume 37 Issue 09, pp 1060-1067Abstract
CONCLUSION: The experience of specific SHCs in the first 6 months after an SCI is related to greater long-term disability. In order to reduce the disability burden of people with SCI, efforts should be directed toward early prevention of these SHCs. PMID: 30882288 [PubMed - as supplied by publisher]
This study determines acute changes in start-up wheelchair propulsion biomechanics at the end of a fatiguing propulsion protocol. DESIGN: Quasi-experimental one-group pretest-postest design. SETTING: Biomechanics laboratory. PARTICIPANTS: Twenty-six wheelchair users with spinal cord injury (age: 35.5 ± 9.8 years, sex: 73% males and 73% with a paraplegia). INTERVENTIONS: Protocol of 15 min including maximum voluntary propulsion, right- and left turns, full stops, start-up propulsion, and rests. OUTCOME MEASURES: Maximum resultant force, maximum rate of rise of applied force, mean vel...
Research ArticlesAnamitra Barik, Rajesh Kumar Rai, Abhijit Chowdhury,Primary Health Care Research&Development,Volume 17 Issue 05, pp 514-523Abstract
More News: Actemra | Arthritis | Ashwagandha | Back Pain | Black Pepper | Cardiology | Cardiovascular | Celebrex | Chemistry | Clinical Trials | Enbrel | Ginseng | Glucosamine | Heart | Heart Attack | Heart Failure | Heart Transplant | Herbs | Honey | Hormones | India Health | Japan Health | Lung Transplant | Milk | Organic | Osteoarthritis | Pain | Pharmaceuticals | Rheumatoid Arthritis | Rheumatology | Stroke | Study | Switzerland Health | Turmeric | Warnings